Jubilant Ingrevia Ltd.
NSE: JUBLINGREA · Specialty Chemicals
Snapshot
Unlock Jubilant Ingrevia Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Jubilant Ingrevia Limited is an integrated life sciences company that provides specialty chemicals, nutrition and health solutions, and life science chemicals. The company serves a diverse global customer base across the pharmaceutical, agrochemical, nutrition, and industrial sectors.
Business Model
The company generates revenue through the manufacturing and sale of high-value chemical intermediates, nutritional ingredients, and specialty ethanol products. It also leverages its technical expertise to provide custom development and manufacturing services, including process optimization and scale-up for industrial clients.
Growth Outlook
Growth is driven by the expansion of its custom development and manufacturing services and the increasing demand for its specialized pyridine-based derivatives. The company continues to focus on process innovation and capacity enhancement to serve its pharmaceutical and agrochemical end-markets.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key feedstocks and petrochemical derivatives can significantly impact operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations and safety standards that may necessitate ongoing capital expenditure.
- Geopolitical and Trade Risks. As an international supplier, the company is exposed to shifts in global trade policies, tariffs, and supply chain disruptions.
- Cyclicality of End-Markets. Demand for specialty chemicals and nutritional ingredients is linked to the performance of the pharmaceutical and agrochemical industries, which can be cyclical.
Start your research today
Unlock AI insights, financials, peers and live data on Jubilant Ingrevia Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,651 Cr
TTM · consolidated
NET PROFIT
₹309 Cr
TTM · consolidated
EPS
₹19.54
TTM · consolidated
RETURN ON EQUITY
10.2%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
12.4%
TTM · consolidated
P/E
34.8x
Q1 FY27 · consolidated
EV/EBITDA
17.2x
Q1 FY27 · consolidated
EBITDA MARGIN
14.3%
TTM · consolidated
NET PROFIT MARGIN
8.1%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.2%
Q1 FY27 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Jubilant Ingrevia Ltd.JUBLINGREA | ₹10,836 Cr | 34.82 | 17.24 | 11.0% | 14.3% | 10.2% | 12.4% | -7.0% |
Privi Speciality Chemicals LimitedPRIVISCL | ₹13,154 Cr | 37.60 | 20.41 | 21.6% | 25.9% | 27.2% | 29.1% | +50.7% |
Alkyl Amines Chemicals Ltd.ALKYLAMINE | ₹10,336 Cr | 45.90 | 27.33 | 5.1% | 22.6% | 15.3% | 18.8% | -3.7% |
ELANTAS Beck India LimitedELANTAS | ₹9,687 Cr | — | — | — | 20.0% | — | — | +12.3% |
Clean Science and Technology Ltd.CLEAN | ₹8,887 Cr | 38.15 | 22.54 | -0.4% | 40.0% | 15.5% | 20.4% | -27.6% |
Balaji Amines LimitedBALAMINES | ₹8,182 Cr | 39.91 | 23.42 | 11.1% | 23.1% | 11.0% | 13.3% | +67.9% |
As of Q1 FY27
Financials
Jubilant Ingrevia Ltd.
NSE: JUBLINGREA · Specialty Chemicals
Snapshot
Unlock Jubilant Ingrevia Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Jubilant Ingrevia Limited is an integrated life sciences company that provides specialty chemicals, nutrition and health solutions, and life science chemicals. The company serves a diverse global customer base across the pharmaceutical, agrochemical, nutrition, and industrial sectors.
Business Model
The company generates revenue through the manufacturing and sale of high-value chemical intermediates, nutritional ingredients, and specialty ethanol products. It also leverages its technical expertise to provide custom development and manufacturing services, including process optimization and scale-up for industrial clients.
Growth Outlook
Growth is driven by the expansion of its custom development and manufacturing services and the increasing demand for its specialized pyridine-based derivatives. The company continues to focus on process innovation and capacity enhancement to serve its pharmaceutical and agrochemical end-markets.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key feedstocks and petrochemical derivatives can significantly impact operating margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations and safety standards that may necessitate ongoing capital expenditure.
- Geopolitical and Trade Risks. As an international supplier, the company is exposed to shifts in global trade policies, tariffs, and supply chain disruptions.
- Cyclicality of End-Markets. Demand for specialty chemicals and nutritional ingredients is linked to the performance of the pharmaceutical and agrochemical industries, which can be cyclical.
Start your research today
Unlock AI insights, financials, peers and live data on Jubilant Ingrevia Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,651 Cr
TTM · consolidated
NET PROFIT
₹309 Cr
TTM · consolidated
EPS
₹19.54
TTM · consolidated
RETURN ON EQUITY
10.2%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
12.4%
TTM · consolidated
P/E
34.8x
Q1 FY27 · consolidated
EV/EBITDA
17.2x
Q1 FY27 · consolidated
EBITDA MARGIN
14.3%
TTM · consolidated
NET PROFIT MARGIN
8.1%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.2%
Q1 FY27 · consolidated
Peers · Specialty Chemicals
As of Q1 FY27